Celprogen Launches Cancer Stem Cells
News Jan 24, 2008
Celprogen Inc. has announced that they have successfully isolated and propagated 11 major cancer stem cells. These Cancer Stems were launched in May 2007 at the AACR meeting in Los Angeles and also in December 2007 at ASCB in Washington DC.
Celprogen’s cancer stem cells are available for basic science research and drug discovery. The cancer stem cells are as follows: Brain, Breast, Colon, Kidney, Leukemia, Liver, Lungs, Melanoma, Ovarian, and Pancreatic & Prostate.
Celprogen provides the Cancer Stem Cell Tissue culture system which includes cells, pre-coated flasks with extracellular matrix and Medium for growth and proliferation of these cells.
Stem Cells in Menstrual Blood Could Help Diagnose EndometriosisNews
The Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately 176 million women globally.READ MORE